CISO Global, Inc. (CISO): Nasdaq/NYSE listing notice — CISO Global receives Nasdaq deficiency notice for bid price below $1.00

CISO Global, Inc.

Received Nasdaq letter on Dec 30, 2025; common stock bid price below $1.00 for 33 consecutive business days.
Must regain compliance by June 29, 2026, with closing bid price >= $1.00 for 10 consecutive business days.
If not compliant by June 29, 2026, may be eligible for additional 180-day cure period if other listing standards met.
Company intends to monitor bid price and consider options including reverse stock split; no immediate delisting effect.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

CISO Global, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

December 30, 2025, we received a letter from the listing qualifications staff (the “Staff”) of Nasdaq providing notification that the bid price of our common stock had closed below $1.00 per share for the previous 33 consecutive business days and our common stock no longer meets the minimum bid price requirement for continued listing under Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), we have 180 calendar days or until June 29, 2026, to regain compliance. To regain compliance, the closing bid price of our common stock must be $1.00 per share or more for

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

CISO Global, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-000105

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.